The Nutshell

» cancer and funding

Daily News Roundup

Most Recent

image: #IceBucketChallenge Payoff

#IceBucketChallenge Payoff

By | August 20, 2015

A year after the viral ALS awareness campaign raised millions, researchers say they have something to show for the influx of funds.

0 Comments

image: Report: Impact of Biomedical Research Slipping

Report: Impact of Biomedical Research Slipping

By | August 18, 2015

Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.

15 Comments

image: Esteemed Cancer Surgeon Dies

Esteemed Cancer Surgeon Dies

By | August 12, 2015

Carolyn Kaelin, a breast cancer surgeon, survivor, and advocate has passed away at age 54.

0 Comments

image: Resveratrol’s Low-Dose Anticancer Effect

Resveratrol’s Low-Dose Anticancer Effect

By | July 31, 2015

The antioxidant found in red wine and some berries shows that small doses have more potent antitumor effects than large doses in a mouse model.

0 Comments

image: Biotech Buys Autoimmune Firm for $7B

Biotech Buys Autoimmune Firm for $7B

By | July 16, 2015

Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.

0 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: The Death Toll Tied to Sweet Drinks

The Death Toll Tied to Sweet Drinks

By | July 1, 2015

Annually, about 184,000 deaths annually are linked to drinking sugary beverages, according to a new study.

7 Comments

image: The Cost of Irreproducible Research

The Cost of Irreproducible Research

By | June 10, 2015

Half of basic science studies cannot be replicated, according to a new analysis—to the tune of $28 billion a year in the U.S.

5 Comments

image: More Lab-Made Nucleotides

More Lab-Made Nucleotides

By | June 8, 2015

Artificial bases that act like the real deal can be designed to bind specifically to tumor cells.

0 Comments

image: NCI Gets Personal

NCI Gets Personal

By | June 2, 2015

The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.

0 Comments

Popular Now

  1. Exercise-Induced Muscle Factor Promotes Memory
  2. Illustrating #FieldworkFails
  3. Transmissible Cancers Plague Mollusks
  4. Single Bacterial Species Improves Autism-Like Behavior in Mice
Biosearch Technologies